Abivax H1 net loss widens on higher clinical-program expenses
Abivax reported a wider H1 net loss, attributed to higher expenses driven by clinical programs, according to its press-release overview.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.